123 related articles for article (PubMed ID: 7579560)
1. Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone.
Saunders DE; Christensen C; Williams JR; Wappler NL; Lawrence WD; Malone JM; Malviya VK; Deppe G
Anticancer Drugs; 1995 Aug; 6(4):562-9. PubMed ID: 7579560
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone.
Saunders DE; Christensen C; Wappler NL; Schultz JF; Lawrence WD; Malviya VK; Malone JM; Deppe G
Anticancer Drugs; 1993 Apr; 4(2):201-8. PubMed ID: 8490200
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.
Koga M; Sutherland RL
J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):455-60. PubMed ID: 1654997
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
[TBL] [Abstract][Full Text] [Related]
5. Decrease in CGRP and CT levels either contained in or released by CA-77 C cells after combined treatments with 1,25-dihydroxyvitamin D3 analogues and 9-cis retinoic acid.
Lamari Y; Garel JM
Reprod Nutr Dev; 1997; 37(1):3-12. PubMed ID: 9115594
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.
Wang Q; Lee D; Sysounthone V; Chandraratna RAS ; Christakos S; Korah R; Wieder R
Breast Cancer Res Treat; 2001 May; 67(2):157-68. PubMed ID: 11519864
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937.
Taimi M; Chateau MT; Cabane S; Marti J
Leuk Res; 1991; 15(12):1145-52. PubMed ID: 1766263
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.
Blutt SE; Allegretto EA; Pike JW; Weigel NL
Endocrinology; 1997 Apr; 138(4):1491-7. PubMed ID: 9075707
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 interaction with dexamethasone and retinoic acid: effects on procollagen messenger ribonucleic acid levels in rat osteoblast-like cells.
Kim HT; Chen TL
Mol Endocrinol; 1989 Jan; 3(1):97-104. PubMed ID: 2915650
[TBL] [Abstract][Full Text] [Related]
11. Effects of trans-retinoic acid, 9-cis-retinoic acid, 1alpha,25-(dihydroxy)vitamin D3 and a novel apoptosis-inducing retinoid on breast cancer and endothelial cell growth.
Dawson MI; Chao WR; Hobbs PD; Zhang XK
Cancer Lett; 1998 Nov; 133(1):1-8. PubMed ID: 9929154
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
Demirpence E; Balaguer P; Trousse F; Nicolas JC; Pons M; Gagne D
Cancer Res; 1994 Mar; 54(6):1458-64. PubMed ID: 8137248
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of 8-Cl-cAMP and retinoic acids in the inhibition of growth and induction of apoptosis in ovarian cancer cells: induction of retinoic acid receptor beta.
Srivastava RK; Srivastave AR; Cho-Chung YS
Mol Cell Biochem; 2000 Jan; 204(1-2):1-9. PubMed ID: 10718618
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
16. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells.
Zugmaier G; Jäger R; Grage B; Gottardis MM; Havemann K; Knabbe C
Br J Cancer; 1996 Jun; 73(11):1341-6. PubMed ID: 8645577
[TBL] [Abstract][Full Text] [Related]
17. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
19. Synergism and antagonism in the effects of 1 alpha,25-dihydroxyvitamin D3, retinoic acid, dexamethasone, and a tumor-promoting phorbol ester on the functional capability of P388D1 cells: phagocytosis and transglutaminase activity.
Goldman R
Cancer Res; 1985 Jul; 45(7):3118-24. PubMed ID: 2860969
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid and glucocorticoids enhance the effect of 1,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid protein synthesis by rat osteosarcoma cells.
Nishimoto SK; Salka C; Nimni ME
J Bone Miner Res; 1987 Dec; 2(6):571-7. PubMed ID: 3484302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
